nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—respiratory system—chronic obstructive pulmonary disease	0.0138	0.209	CbGeAlD
Ibandronate—FDPS—connective tissue—chronic obstructive pulmonary disease	0.0121	0.184	CbGeAlD
Ibandronate—FDPS—bronchus—chronic obstructive pulmonary disease	0.0113	0.172	CbGeAlD
Ibandronate—FDPS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0111	0.168	CbGeAlD
Ibandronate—FDPS—trachea—chronic obstructive pulmonary disease	0.0102	0.155	CbGeAlD
Ibandronate—FDPS—lung—chronic obstructive pulmonary disease	0.0073	0.111	CbGeAlD
Ibandronate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00136	CcSEcCtD
Ibandronate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Ibandronate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Ibandronate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Ibandronate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00133	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00133	CcSEcCtD
Ibandronate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Ibandronate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Ibandronate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Ibandronate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Ibandronate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00131	CcSEcCtD
Ibandronate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Ibandronate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Ibandronate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Ibandronate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Ibandronate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Ibandronate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00129	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00129	CcSEcCtD
Ibandronate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00128	CcSEcCtD
Ibandronate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00128	CcSEcCtD
Ibandronate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00127	CcSEcCtD
Ibandronate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00127	CcSEcCtD
Ibandronate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00127	CcSEcCtD
Ibandronate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00127	CcSEcCtD
Ibandronate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00127	CcSEcCtD
Ibandronate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00126	CcSEcCtD
Ibandronate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00126	CcSEcCtD
Ibandronate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Ibandronate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Ibandronate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Ibandronate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Ibandronate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Ibandronate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00124	CcSEcCtD
Ibandronate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00124	CcSEcCtD
Ibandronate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Ibandronate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Ibandronate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Ibandronate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Ibandronate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Ibandronate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.0012	CcSEcCtD
Ibandronate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.0012	CcSEcCtD
Ibandronate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00119	CcSEcCtD
Ibandronate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00118	CcSEcCtD
Ibandronate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00117	CcSEcCtD
Ibandronate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Ibandronate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Ibandronate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00115	CcSEcCtD
Ibandronate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00115	CcSEcCtD
Ibandronate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00114	CcSEcCtD
Ibandronate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00113	CcSEcCtD
Ibandronate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00113	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00113	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00113	CcSEcCtD
Ibandronate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00112	CcSEcCtD
Ibandronate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00112	CcSEcCtD
Ibandronate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00111	CcSEcCtD
Ibandronate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00103	0.0011	CcSEcCtD
Ibandronate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00109	CcSEcCtD
Ibandronate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00109	CcSEcCtD
Ibandronate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00109	CcSEcCtD
Ibandronate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00109	CcSEcCtD
Ibandronate—Injury—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00108	CcSEcCtD
Ibandronate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00108	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.001	0.00107	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00107	CcSEcCtD
Ibandronate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.001	0.00107	CcSEcCtD
Ibandronate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00107	CcSEcCtD
Ibandronate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.001	0.00107	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000999	0.00107	CcSEcCtD
Ibandronate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000993	0.00106	CcSEcCtD
Ibandronate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000993	0.00106	CcSEcCtD
Ibandronate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000993	0.00106	CcSEcCtD
Ibandronate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000993	0.00106	CcSEcCtD
Ibandronate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000992	0.00106	CcSEcCtD
Ibandronate—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00099	0.00106	CcSEcCtD
Ibandronate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000985	0.00105	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000982	0.00105	CcSEcCtD
Ibandronate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000981	0.00105	CcSEcCtD
Ibandronate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000973	0.00104	CcSEcCtD
Ibandronate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00097	0.00104	CcSEcCtD
Ibandronate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000965	0.00103	CcSEcCtD
Ibandronate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000962	0.00103	CcSEcCtD
Ibandronate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000961	0.00103	CcSEcCtD
Ibandronate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000957	0.00102	CcSEcCtD
Ibandronate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000957	0.00102	CcSEcCtD
Ibandronate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000956	0.00102	CcSEcCtD
Ibandronate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000953	0.00102	CcSEcCtD
Ibandronate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000952	0.00102	CcSEcCtD
Ibandronate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00095	0.00102	CcSEcCtD
Ibandronate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00095	0.00102	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000947	0.00101	CcSEcCtD
Ibandronate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000946	0.00101	CcSEcCtD
Ibandronate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000938	0.001	CcSEcCtD
Ibandronate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000938	0.001	CcSEcCtD
Ibandronate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00093	0.000996	CcSEcCtD
Ibandronate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00093	0.000995	CcSEcCtD
Ibandronate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.000988	CcSEcCtD
Ibandronate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000923	0.000988	CcSEcCtD
Ibandronate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000918	0.000983	CcSEcCtD
Ibandronate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000918	0.000983	CcSEcCtD
Ibandronate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000918	0.000983	CcSEcCtD
Ibandronate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000918	0.000983	CcSEcCtD
Ibandronate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000915	0.000979	CcSEcCtD
Ibandronate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000907	0.000971	CcSEcCtD
Ibandronate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000907	0.00097	CcSEcCtD
Ibandronate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000907	0.00097	CcSEcCtD
Ibandronate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000904	0.000967	CcSEcCtD
Ibandronate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.000967	CcSEcCtD
Ibandronate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000902	0.000965	CcSEcCtD
Ibandronate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000899	0.000963	CcSEcCtD
Ibandronate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000899	0.000963	CcSEcCtD
Ibandronate—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000898	0.000961	CcSEcCtD
Ibandronate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000897	0.00096	CcSEcCtD
Ibandronate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00089	0.000953	CcSEcCtD
Ibandronate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000885	0.000948	CcSEcCtD
Ibandronate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.000933	CcSEcCtD
Ibandronate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000867	0.000928	CcSEcCtD
Ibandronate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000867	0.000928	CcSEcCtD
Ibandronate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000856	0.000916	CcSEcCtD
Ibandronate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000856	0.000916	CcSEcCtD
Ibandronate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000855	0.000915	CcSEcCtD
Ibandronate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000838	0.000897	CcSEcCtD
Ibandronate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000833	0.000892	CcSEcCtD
Ibandronate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000833	0.000892	CcSEcCtD
Ibandronate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000822	0.00088	CcSEcCtD
Ibandronate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000822	0.00088	CcSEcCtD
Ibandronate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000816	0.000874	CcSEcCtD
Ibandronate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000808	0.000865	CcSEcCtD
Ibandronate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000805	0.000862	CcSEcCtD
Ibandronate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000795	0.000851	CcSEcCtD
Ibandronate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000795	0.000851	CcSEcCtD
Ibandronate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000787	0.000842	CcSEcCtD
Ibandronate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000778	0.000833	CcSEcCtD
Ibandronate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000776	0.000831	CcSEcCtD
Ibandronate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000771	0.000825	CcSEcCtD
Ibandronate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000768	0.000822	CcSEcCtD
Ibandronate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000768	0.000822	CcSEcCtD
Ibandronate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000752	0.000805	CcSEcCtD
Ibandronate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00075	0.000803	CcSEcCtD
Ibandronate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000739	0.00079	CcSEcCtD
Ibandronate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000739	0.00079	CcSEcCtD
Ibandronate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000732	0.000784	CcSEcCtD
Ibandronate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.000784	CcSEcCtD
Ibandronate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000732	0.000783	CcSEcCtD
Ibandronate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.000783	CcSEcCtD
Ibandronate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000728	0.000779	CcSEcCtD
Ibandronate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000728	0.000779	CcSEcCtD
Ibandronate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000727	0.000778	CcSEcCtD
Ibandronate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.000776	CcSEcCtD
Ibandronate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000723	0.000774	CcSEcCtD
Ibandronate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000717	0.000768	CcSEcCtD
Ibandronate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000717	0.000767	CcSEcCtD
Ibandronate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000715	0.000765	CcSEcCtD
Ibandronate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000715	0.000765	CcSEcCtD
Ibandronate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000713	0.000763	CcSEcCtD
Ibandronate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000704	0.000754	CcSEcCtD
Ibandronate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.000746	CcSEcCtD
Ibandronate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000695	0.000744	CcSEcCtD
Ibandronate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000692	0.000741	CcSEcCtD
Ibandronate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00074	CcSEcCtD
Ibandronate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.000739	CcSEcCtD
Ibandronate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00069	0.000738	CcSEcCtD
Ibandronate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.000738	CcSEcCtD
Ibandronate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.000735	CcSEcCtD
Ibandronate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000676	0.000723	CcSEcCtD
Ibandronate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000665	0.000712	CcSEcCtD
Ibandronate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.000697	CcSEcCtD
Ibandronate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000648	0.000694	CcSEcCtD
Ibandronate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000647	0.000692	CcSEcCtD
Ibandronate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000643	0.000689	CcSEcCtD
Ibandronate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000632	0.000677	CcSEcCtD
Ibandronate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000629	0.000673	CcSEcCtD
Ibandronate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000619	0.000662	CcSEcCtD
Ibandronate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000608	0.000651	CcSEcCtD
Ibandronate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000601	0.000644	CcSEcCtD
Ibandronate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000584	0.000625	CcSEcCtD
Ibandronate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000581	0.000622	CcSEcCtD
Ibandronate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000569	0.000609	CcSEcCtD
Ibandronate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000569	0.000609	CcSEcCtD
Ibandronate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000565	0.000605	CcSEcCtD
Ibandronate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000564	0.000603	CcSEcCtD
Ibandronate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00056	0.000599	CcSEcCtD
Ibandronate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00056	0.000599	CcSEcCtD
Ibandronate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000538	0.000576	CcSEcCtD
Ibandronate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00052	0.000556	CcSEcCtD
Ibandronate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000518	0.000555	CcSEcCtD
Ibandronate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000518	0.000554	CcSEcCtD
Ibandronate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000512	0.000548	CcSEcCtD
Ibandronate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000505	0.000541	CcSEcCtD
Ibandronate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000503	0.000539	CcSEcCtD
Ibandronate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.0005	0.000535	CcSEcCtD
Ibandronate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000484	0.000518	CcSEcCtD
Ibandronate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00051	CcSEcCtD
Ibandronate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00051	CcSEcCtD
Ibandronate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000475	0.000509	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000474	0.000507	CcSEcCtD
Ibandronate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000471	0.000504	CcSEcCtD
Ibandronate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000463	0.000496	CcSEcCtD
Ibandronate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000457	0.000489	CcSEcCtD
Ibandronate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000486	CcSEcCtD
Ibandronate—Shock—Prednisone—chronic obstructive pulmonary disease	0.00045	0.000481	CcSEcCtD
Ibandronate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00048	CcSEcCtD
Ibandronate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000444	0.000475	CcSEcCtD
Ibandronate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000442	0.000473	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000416	0.000446	CcSEcCtD
Ibandronate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000416	0.000445	CcSEcCtD
Ibandronate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000443	CcSEcCtD
Ibandronate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00041	0.000439	CcSEcCtD
Ibandronate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000402	0.000431	CcSEcCtD
Ibandronate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000397	0.000425	CcSEcCtD
Ibandronate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.000425	CcSEcCtD
Ibandronate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.000424	CcSEcCtD
Ibandronate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000394	0.000422	CcSEcCtD
Ibandronate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.000422	CcSEcCtD
Ibandronate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000391	0.000418	CcSEcCtD
Ibandronate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000377	0.000403	CcSEcCtD
Ibandronate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000374	0.0004	CcSEcCtD
Ibandronate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000374	0.0004	CcSEcCtD
Ibandronate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000389	CcSEcCtD
Ibandronate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000387	CcSEcCtD
Ibandronate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000387	CcSEcCtD
Ibandronate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00036	CcSEcCtD
Ibandronate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000351	CcSEcCtD
Ibandronate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000346	CcSEcCtD
Ibandronate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000313	0.000335	CcSEcCtD
Ibandronate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000302	0.000324	CcSEcCtD
Ibandronate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000311	CcSEcCtD
Ibandronate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000308	CcSEcCtD
Ibandronate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000308	CcSEcCtD
Ibandronate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000307	CcSEcCtD
Ibandronate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000291	CcSEcCtD
